The Travelers Companies, Inc. (TRV) Stock Price & Analysis
The Travelers Companies, Inc. (TRV) closed at USD 405.44 on Thursday, October 22, 2026, up 1.63% on the day. The US market is currently closed (pre-market); this is not a live price.
The prior close was USD 398.95; the Oct 22, 2026 session ranged USD 400.05–407.87 on volume of 1,918,013 shares. Market capitalization is $84.56B, with a 52-week range of USD 264.25–407.87 (NYQ). Source: Nexqual, retrieved October 23, 2026 at 08:35 UTC.
Also available as compact Markdown for AI agents: nexqual.com/TRV.md
Key facts (TRV)
- Last four reported quarters (through Sep 30, 2026): revenue $48.9B, net income $8.33B (17.0% margin) (SEC filings).
- Valuation: P/E 10.1x (avg 12.1x at the last 3 fiscal year-ends), net debt $9.05B.
- 3 of 80 tracked superinvestors hold TRV (13F, Q2 2026): 0 new, 1 added, 1 reduced, 1 unchanged.
- Insider open-market sales, last ~7 months: 18 Form 4 filings, $45.3M; 18 not under a Rule 10b5-1 plan ($45.3M); 10 by opportunistic insiders (10 outside 10b5-1 plans), 4 by routine insiders (three-year test, Cohen, Malloy & Pomorski 2012).
- Analysts: Hold (mean 3.03 on a 1–5 scale) (29 analysts), mean target USD 374.29 (range 262–450).
- Total return with dividends: 1Y +53.0% vs S&P 500 +14.9%; 5Y +174.6% vs S&P 500 +80.3%.
- Next earnings: 2026-10-16, EPS estimate USD 9.95, revenue estimate $11.0B.
Financials (SEC 10-K; TTM = last four 10-Q/10-K quarters) (TRV)
| USD | FY2021 | FY2022 | FY2023 | FY2024 | FY2025 | TTM |
|---|---|---|---|---|---|---|
| Revenue | $34.8B | $36.9B | $41.4B | $46.4B | $48.8B | $48.9B |
| Net income | $3.66B | $2.84B | $2.99B | $5.00B | $6.29B | $8.33B |
| EPS (diluted) | $14.49 | $11.77 | $12.79 | $21.47 | $27.43 | — |
| Net margin | 10.5% | 7.7% | 7.2% | 10.8% | 12.9% | 17.0% |
| Revenue growth | +8.9% | +5.9% | +12.1% | +12.2% | +5.2% | — |
| Cash + short-term investments | $761M | $799M | $650M | $699M | $842M | — |
| Total debt | $7.29B | $7.29B | $8.03B | $8.03B | $9.27B | — |
Fiscal years end Dec. EPS is split-adjusted.
Valuation (price ÷ last four quarters, through Sep 30, 2026) (TRV)
P/E 10.1x · P/S 1.7x · EV/Sales 1.9x · P/B 2.9x · Earnings yield 9.85% · Dividend yield (paid, TTM) 1.18% · Buyback yield (TTM) 7.36% · Net debt $9.05B · EV $93.6B
P/E at fiscal year-ends: Dec 2025 10.5x, Dec 2024 11.1x, Dec 2023 14.8x.
Superinvestors (SEC 13F-HR, Q2 2026) (TRV)
3 of 80 tracked investors hold TRV. Each row is the investor's latest 13F; change is vs their prior-quarter share count.
| Investor | Firm | % of portfolio | Value | Change |
|---|---|---|---|---|
| Christopher Bloomstran | Semper Augustus | 0.71% | $6.3M | Unchanged |
| Mairs & Power | Mairs & Power Funds | 0.47% | $51.7M | Added +9.9% |
| Dodge & Cox Funds | Dodge & Cox | 0.02% | $29.8M | Reduced -2.9% |
Insider sales (SEC Form 4, open-market, last ~7 months) (TRV)
0 of 18 under a Rule 10b5-1 trading plan (scheduled in advance). Unplanned sales were timed by the insider.
| Trade date | Insider | Role | Shares | Value | % of holdings sold | 10b5-1 plan | Insider type |
|---|---|---|---|---|---|---|---|
| 2026-10-21 | Olivo Maria | EVP, ERM & Chief Risk Officer | 15,100 | $6.0M | 12.7% | No | Routine (sold in Nov each year 2023–2025; this trade is outside those months) |
| 2026-10-20 | Klein Michael Frederick | EVP & President, Personal Ins. | 7,500 | $2.9M | 13.8% | No | Opportunistic (traded every year 2023–2025, no repeating month) |
| 2026-08-28 | Olivo Maria | EVP, ERM & Chief Risk Officer | 6,000 | $2.2M | 4.8% | No | Routine (sold in Nov each year 2023–2025; this trade is outside those months) |
| 2026-07-24 | Yin Daniel Tei-Hwa | EVP & Co-Chief Invest. Officer | 7,153 | $2.8M | 9.4% | No | Too little history (no open-market trades in 2023 or 2025) |
| 2026-07-24 | Kurtzman Diane | EVP & Chief HR Officer | 4,164 | $1.6M | 44% | No | Opportunistic (traded every year 2023–2025, no repeating month) |
| 2026-07-22 | Rowland David Donnay | EVP & Co-Chief Invest. Officer | 5,000 | $1.9M | 11.5% | No | Too little history (no open-market trades in 2023) |
| 2026-07-22 | Munson Paul E. | SVP & Corp. Controller | 1,525 | $564K | 67.5% | No | Too little history (no open-market trades in 2023) |
| 2026-07-22 | Bessette Andy F | EVP and Chief Admin Officer | 3,000 | $1.1M | 11.5% | No | Opportunistic (traded every year 2023–2025, no repeating month) |
| 2026-07-21 | Klein Michael Frederick | EVP & President, Personal Ins. | 6,000 | $2.2M | 11.3% | No | Opportunistic (traded every year 2023–2025, no repeating month) |
| 2026-07-21 | Frey Daniel S. | EVP & Chief Financial Officer | 14,037 | $5.2M | 33.8% | No | Opportunistic (traded every year 2023–2025, no repeating month) |
| 2026-07-21 | Lefebvre Mojgan M | EVP & Chief Tech & Ops Officer | 16,313 | $6.0M | 100% | No | Routine (sold in Feb each year 2023–2025; this trade is outside those months) |
| 2026-05-26 | Klein Michael Frederick | EVP & President, Personal Ins. | 10,000 | $3.1M | 17.5% | No | Opportunistic (traded every year 2023–2025, no repeating month) |
| 2026-05-22 | Bessette Andy F | EVP and Chief Admin Officer | 4,255 | $1.3M | 14.1% | No | Opportunistic (traded every year 2023–2025, no repeating month) |
| 2026-04-28 | Kess Avrohom J. | Vice Chmn. & Chief Legal Off. | 6,735 | $2.1M | 12.1% | No | Too little history (no open-market trades in 2023 or 2024) |
| 2026-04-28 | Heyman William H | Vice Chairman | 1,557 | $484K | 0.6% | No | Routine (sold in Nov each year 2023–2025; this trade is outside those months) |
| 2026-04-20 | Kurtzman Diane | EVP & Chief HR Officer | 2,867 | $870K | 35.1% | No | Opportunistic (traded every year 2023–2025, no repeating month) |
| 2026-04-20 | Klein Michael Frederick | EVP & President, Personal Ins. | 10,000 | $3.0M | 17.5% | No | Opportunistic (traded every year 2023–2025, no repeating month) |
| 2026-04-20 | Klenk Jeffrey P. | EVP & Pres., Bond & Spec. Ins. | 6,414 | $2.0M | 51.4% | No | Opportunistic (traded every year 2023–2025, no repeating month) |
% of holdings sold = shares sold ÷ (shares sold + all holdings the insider reported on that Form 4, direct and through trusts).
Insider type follows Cohen, Malloy & Pomorski (Journal of Finance, 2012). An insider who traded the stock in the same calendar month in each of the past three years is a routine trader; one who traded in each of those years without such a pattern is an opportunistic trader. In their study, trades by opportunistic insiders predicted future returns and trades by routine insiders did not. Counts open-market purchases and sales only (SEC Form 4 codes P and S) by that insider in that company. Not investment advice.
Analysts (TRV)
Consensus Hold (mean 3.03 on a 1–5 scale), 29 analysts; mean target USD 374.29 (low 262, high 450).
Rating changes, last 120 days:
| Date | Firm | Action | Rating | Price target |
|---|---|---|---|---|
| 2026-10-20 | BMO Capital | Target raised | Market Perform | $379 → $388 |
| 2026-10-20 | JP Morgan | Target raised | Neutral | $352 → $379 |
| 2026-10-20 | Mizuho | Target raised | Neutral | $345 → $371 |
| 2026-10-20 | Keefe, Bruyette & Woods | Target raised | Market Perform | $372 → $382 |
| 2026-10-19 | Wells Fargo | Target raised | Equal-Weight | $341 → $377 |
| 2026-10-19 | Evercore ISI Group | Target raised | In-Line | $349 → $372 |
| 2026-10-19 | Truist Securities | Target raised | Buy | $425 → $435 |
| 2026-10-12 | Wells Fargo | Target lowered | Equal-Weight | $356 → $341 |
| 2026-10-09 | JP Morgan | Target raised | Neutral | $348 → $352 |
| 2026-10-07 | Mizuho | Target lowered | Neutral | $348 → $345 |
| 2026-10-07 | Cantor Fitzgerald | Target raised | Overweight | $377 → $378 |
| 2026-09-21 | Evercore ISI Group | Target raised | In-Line | $338 → $342 |
Total return (dividends reinvested) (TRV)
| 1Y (from 2025-10-23) | 5Y (from 2021-10-18) | |
|---|---|---|
| Total return | +53.0% | +174.6% |
| S&P 500 (SPY) | +14.9% | +80.3% |
| Per year | +53.2% | +22.3% |
| Volatility (annualized) | 20.4% | 20.7% |
| Max drawdown | -9.9% (Jul 2026→Sep 2026) | -17.5% (Mar 2022→Sep 2022) |
TRV revenue by region (fiscal year ended Dec 31, 2025)
| Line | Revenue | Share of total | YoY |
|---|---|---|---|
| Domestic | $46.36B | 94.9% | +5.5% |
| International | $2.47B | 5.1% | -1.2% |
| — Canada (part of International) | $1.34B | 2.8% | -1.0% |
| — Other Non United States (part of International) | $1.12B | 2.3% | -1.5% |
| Total revenue | $48.83B | 100% | — |
As tagged by the company in its SEC 10-Q / 10-K filings (XBRL).
TRV suppliers, customers and competitors (named in its 10-K)
| Relationship | Company | Sentence in the filing |
|---|---|---|
| Partner | Fidelis Insurance Holdings | “In addition, we conduct business in Brazil through a joint venture, and throughout other parts of the world, including as a corporate member of Lloyd's and through our quota share agreement with Fidelis.” |
Quoted from the company's 10-K filed Feb 12, 2026.
TRV analyst estimates and revisions
| Period | EPS estimate | 90 days ago | Change | Revenue estimate | Analysts |
|---|---|---|---|---|---|
| Current quarter (ends Dec 2026) | $9.95 | $9.61 | +3.6% | $11.01B | 24 |
| Next quarter (ends Mar 2027) | $7.83 | $7.71 | +1.5% | $10.97B | 22 |
| Current fiscal year (ends Dec 2026) | $36.82 | $34.13 | +7.9% | $43.50B | 25 |
| Next fiscal year (ends Dec 2027) | $31.01 | $30.13 | +2.9% | $44.44B | 26 |
TRV options: expected move
| Expiration | Days | ATM implied volatility | Expected move |
|---|---|---|---|
| Nov 20, 2026 | 28 | 23.0% | ±5.3% |
| Dec 18, 2026 | 56 | 22.4% | ±7.2% |
| Jan 15, 2027 | 84 | 22.6% | ±8.8% |
| Apr 16, 2027 | 175 | 23.8% | ±13.3% |
| Jun 17, 2027 | 237 | 24.3% | ±15.7% |
| Sep 17, 2027 | 329 | 24.5% | ±18.6% |
30-day implied volatility 23% vs 19.1% realized over the last 30 trading days. Put/call ratio (volume) 2.22. Cboe delayed quotes (15 min). Expected move = at-the-money straddle.
Key Statistics (as of October 23, 2026 at 08:35 UTC)
| Price | USD 405.44 |
|---|---|
| Change | ▲ 1.63% (up) |
| Previous Close | USD 398.95 |
| Open | USD 400.11 |
| Day Range | USD 400.05 – 407.87 |
| 52-Week Range | USD 264.25 – 407.87 |
| Volume | 1,918,013 shares |
| Market Cap | $84.56B |
| Exchange | NYQ |
Technical Analysis (TRV)
Nexqual's technical model rates TRV "BUY" based on 5 bullish and 3 bearish signals across 127 daily candles, as of October 23, 2026 at 08:35 UTC.
| Overall Signal | BUY |
|---|---|
| RSI (14) | 77.82 (overbought) |
| vs SMA50 | Above (USD 370.89) |
| MACD | 8.07 (positive) |
Analyst Ratings (TRV)
Wall Street analysts rate TRV "Hold" based on 29 analysts, with a mean price target of USD 374.29 (range USD 262–450), per Nexqual as of October 23, 2026 at 08:35 UTC.
| Consensus Rating | Hold |
|---|---|
| Analyst Count | 29 |
| Mean Target | USD 374.29 |
| High Target | USD 450 |
| Low Target | USD 262 |
| Buy / Hold / Sell | 6 / 17 / 6 |
Earnings (TRV)
| Next Earnings Date | 2026-10-16 |
|---|---|
| EPS Estimate | USD 9.95 |
| Revenue Estimate | $11.01B |
Recent Earnings History
| Quarter | Actual vs Estimate |
|---|---|
| 2026-09-30 | USD 9.18 vs est 7.43 ▲ beat |
| 2026-06-30 | USD 10.04 vs est 5.39 ▲ beat |
| 2026-03-31 | USD 7.71 vs est 7.08 ▲ beat |
| 2025-12-31 | USD 11.13 vs est 8.8 ▲ beat |
Source: Nexqual, October 23, 2026 at 08:35 UTC.
Financials & Fundamentals (TRV)
| Total Revenue | $48.92B |
|---|---|
| Revenue Growth (latest quarter, YoY) | -0.50% |
| Gross Margin | +34.86% |
| Operating Margin | +20.04% |
| Profit Margin | +17.03% |
| ROE | +27.50% |
| Debt / Equity | 0.34 |
| Current Ratio | 0.33 |
| Total Cash | $6.18B |
| Total Debt | $9.81B |
Source: Nexqual, October 23, 2026 at 08:35 UTC.
Financial Health Score (TRV)
Nexqual rates The Travelers Companies, Inc.'s overall financial health "Solid" across five dimensions, as of October 23, 2026 at 08:35 UTC.
| Growth | Mixed — Revenue +4.7% YoY (annual), slow |
|---|---|
| Profitability | Solid — Gross margin 35%, operating 20% (last 12 months) |
| Balance Sheet | Mixed — $766M cash and investments vs $9.81B debt (Sep 2026, SEC) |
| Cash Flow | Solid — Operating cash flow $10.6B (FY ended Dec 2025, 10-K) |
| Efficiency | Strong — ROE 27%, ROA 4.7% |
Ownership (TRV)
| Insider Ownership | +0.29% |
|---|---|
| Institutional Ownership | +92.78% |
| Shares Outstanding | 208.58M |
| Float | 203.72M |
| Short % of Float | +3.18% |
Source: Nexqual, October 23, 2026 at 08:35 UTC.
Leadership (TRV)
The Travelers Companies, Inc. is led by Alan David Schnitzer, Chairman & CEO, per Nexqual as of October 23, 2026 at 08:35 UTC.
| Chairman & CEO | Alan David Schnitzer |
|---|---|
| Executive VP & CFO | Daniel Stephen Frey |
| Vice Chairman & Chief Legal Officer | Avrohom J. Kess |
| Executive VP & President of Personal Insurance | Michael Frederick Klein |
| Executive VP & President of Business Insurance | Gregory Cheshire Toczydlowski |
Major Backers & Investors (TRV)
Notable institutional backers of The Travelers Companies, Inc. include FMR, LLC, Massachusetts Financial Services Co., Morgan Stanley, according to Nexqual as of October 23, 2026 at 08:35 UTC.
Active Investors
| Investor | Stake |
|---|---|
| FMR, LLC | 5.01% |
| Massachusetts Financial Services Co. | 2.07% |
| Morgan Stanley | 1.87% |
| MFS SERIES TRUST I-MFS Value Fund | 1.57% |
| JPMorgan | 1.52% |
Index Funds (Passive)
| Fund | Stake |
|---|---|
| Vanguard Group | 10.84% |
| BlackRock | 10.22% |
| State Street | 7.66% |
| Geode Capital | 3.08% |
| Dimensional Fund Advisors | 1.74% |
Source: Nexqual, October 23, 2026 at 08:35 UTC.
From The Travelers Companies, Inc.'s Latest SEC 10-K Filing (filed 2026-02-12)
Key Strengths & Strategy (as disclosed to the SEC)
- With approximately 12,300 employees, Claims Services employs a group of professionals with diverse skills, including claim adjusters, appraisers, attorneys, investigators, engineers, accountants, nurses, data and analytics professionals, system specialists and training, management and support personnel.
- Business Insurance utilizes underwriting, claims, engineering, actuarial and product development disciplines for particular industries, together with extensive amounts of proprietary data gathered and analyzed over many years, as well as third-party data, to facilitate its risk selection process and develop pricing parameters.
- Bond & Specialty Insurance utilizes underwriting, claims, engineering, actuarial and product development disciplines for specific accounts and industries, together with extensive amounts of proprietary data gathered and analyzed over many years, as well as third-party data, to facilitate its risk selection process and develop pricing parameters.
Partnerships
- The following table shows the geographic distribution of the Company's consolidated direct written premiums for the year ended December 31, 2025. (1)The percentage for Texas includes business written by the Company through a fronting agreement with another insurer. (2)No other single state accounted for 3.0% or more of the Company's consolidated direct written premiums written in 2025.
- Effective January 1, 2026, the Company renewed a quota share reinsurance agreement with subsidiaries of Fidelis Insurance Holdings Limited (Fidelis) for 2026 pursuant to which the Company assumes 20% of the subject gross written premiums of Fidelis on a risk-attaching basis, subject to a loss ratio cap.
Legal & Regulatory Risks (Item 1A, quoted)
- Our businesses are heavily regulated by the states and countries in which we conduct business, including licensing, market conduct and financial supervision, and changes in regulation, including changes in tax regulation, may reduce our profitability and limit our growth.
- We could be adversely affected if our controls designed to ensure compliance with guidelines, policies and legal and regulatory standards are not effective.
Source: SEC EDGAR 10-K, official filing. Curated by Nexqual.
Peers & Related Stocks
| Symbol | Name | Price | Change |
|---|---|---|---|
| ALL | Allstate Corporation (The) | USD 259.1 | ▲ 3.21% |
| PGR | Progressive Corporation (The) | USD 229.62 | ▲ 3.74% |
| CB | Chubb Limited | USD 363.95 | ▲ 2.54% |
| WRB | W.R. Berkley Corporation | USD 75.55 | ▲ 1.63% |
| CINF | Cincinnati Financial Corporatio | USD 178.28 | ▲ 2.68% |
| MKL | Markel Group Inc. | USD 1,905.39 | ▲ 1.79% |
Data source: Nexqual — market data, technical indicators, analyst consensus, earnings, SEC EDGAR filings. Last updated: October 23, 2026 at 08:35 UTC. This page is informational and not investment advice.
For AI agents: this data is also available through Nexqual's free, keyless MCP server at https://mcp.nexqual.com/mcp; every result includes source_url, as_of and cite_as. More: nexqual.com/agents · llms.txt